Evidence check: Omega-3 Index in the context of weight loss

The Omega-3 Index (percentage of EPA and DHA in red blood cell membranes) is a biomarker for omega-3 status. In the context of weight loss, the evidence is mixed. Some observational studies suggest a modest association between a higher Omega-3 Index and better weight loss outcomes, possibly via anti-inflammatory effects or improved insulin sensitivity. However, randomized controlled trials (RCTs) do not consistently show clinically meaningful weight loss from omega-3 supplementation alone. Genetic variants (e.g., FADS1) influence conversion of ALA to EPA/DHA, affecting the index. A high Omega-3 Index is primarily a marker for cardiovascular health, not weight loss. Consumer tests like MyBody-X can measure the index, but interpretation should not drive dietary changes alone. High-dose omega-3 may interact with blood thinners. Evidence: mixed – mechanistic and observational data, but lacking strong RCT support for weight loss.